Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Details

Language :

English

ISSN :

10408428

Volume :

39

Issue :

1-2

Database :

Supplemental Index

Journal :

Critical Reviews in Oncology/Hematology

Publication Type :

Periodical

Accession number :

ejs3555356

Full Text :

https://doi.org/10.1016/S1040-8428(01)00107-X